Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA for Ovarian Aging (DITTO)
NCT01572025Phase 3Completed
- Sponsor
- University of Nottingham
- Start
- May 2012
- Primary completion
- Dec 2014
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dehydroepiandrosterone in Diminished Ovarian Reserve (DOR), sponsored by University of Nottingham. Primary endpoint: Number of oocytes retrieved at 15 weeks. Started May 2012; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT01572025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01572025.